Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses Federated Hermes Inc FHI Q1 2026 Earnings EPS Surpasses Estimates by 63 Dominari Holdings Inc DOMH Q1 2024 Earnings Net Loss Per Share of 035 Amid Ongoing Portfolio Management RBB Q1 2026 Earnings Strong EPS Beat Exceeds Estimates Thermo Fisher Scientific Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Pullback Scholastic Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline